Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by RAMAKRISHNA, R
Right arrow Articles by MANOHARAN, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RAMAKRISHNA, R
Right arrow Articles by MANOHARAN, A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1992; 83: 547-554
© 1992 Association of Physicians


research-article

Haematological Manifestations of Primary Sjögren's Syndrome: A Clinicopathological Study

R RAMAKRISHNA, K CHAUDHURI*, A STURGESS* and A MANOHARAN

Departments of Haematology, St. George Hospital Kogarah, NSW, Australia *Rheumatology, St. George Hospital Kogarah, NSW, Australia

Accepted for publication 23 April 1992.

Clinically significant cytopenias are thought to be uncommon in primary Sjögren's syndrome: only a few cases have been reported in the literature. Over a 3-year period we identified haematological abnormalities in 11 of 27 patients with Sjögren's syndrome. Six patients had a positive direct antiglobulin test, including one patient with all the features of autoimmune haemolytic anaemia and two others with some features of this condition. Four patients had immune thrombocytopenia and two patients had myelodysplastic syndrome. Neutropenia was noted in two patients, one patient had aplastic anaemia and one had pure red cell aplasia. Haematological disorders were found to be common in patients with Sjögren's syndrome (40 per cent). Accordingly, we suggest that patients with immune cytopenia(s) should be screened for Sjögren's syndrome using sensitive assays for anti-SS.A and anti-SS.B antibodies, and that patients with Sjögren's syndrome should be periodically monitored, with a full blood count to rule out any haematological abnormality.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. Klepfish, J. Friedman, Y. Schechter, and A. Schattner
Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjogren's syndrome
Rheumatology, August 1, 2001; 40(8): 948 - 949.
[Full Text] [PDF]


Home page
QJMHome page
A. Schattner, J. Friedman, A. Klepfish, and A. Berrebi
Immune cytopenias as the presenting finding in primary Sjogren's syndrome
QJM, December 1, 2000; 93(12): 825 - 829.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.